Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» generics
generics
Why Pacira Biosciences Stock Sank Today
Motley Fool
Mon, 10/4/21 - 11:04 pm
Pacira
eVenus
FDA
generics
EXPAREL
non-opioid pain treatments
Three generic firms shell out $447M more to settle federal price fixing allegations
Endpoints
Mon, 10/4/21 - 10:59 am
generics
legal
price fixing
Taro Pharmaceuticals
Sandoz
Novartis
Apotex
Gilead, Bristol Myers face lawsuit from major pharmacies over HIV generic drug delays
Endpoints
Wed, 09/29/21 - 11:01 am
Gilead Sciences
Teva Pharmaceutical
Bristol Myers Squibb
CVS
Rite Aid
generics
HIV
Faced with generic rivals, Amarin cuts 400-plus sales reps as part of revamped Vascepa strategy
Fierce Pharma
Thu, 09/23/21 - 10:29 pm
Amarin
Vascepa
layoffs
generics
Amgen scores Otezla patent win, protecting its blockbuster from Sandoz and Zydus generics until 2028
Fierce Pharma
Tue, 09/21/21 - 10:54 am
Amgen
Otezla
psoriasis
generics
Sandoz
market exclusivity
patents
Pharmacist-driven biosimilar substitution saves money
GaBI
Sat, 08/28/21 - 09:08 pm
biosimilars
generics
pharmacists
ASCO
Court upholds AbbVie's patents on blockbuster cancer drug Imbruvica, generics unlikely until 2032
Endpoints
Fri, 08/20/21 - 12:33 pm
AbbVie
Imbruvica
patents
legal
generics
FDA seeks input on pre-Hatch-Waxman ‘PANDA’ applications
RAPS.org
Thu, 08/12/21 - 10:56 pm
FDA
Hatch Waxman Act
generics
PANDAs
Pfizer halted Chantix distribution then recalled a dozen batches. Now, a generic's here to help fill the shortage
Fierce Pharma
Thu, 08/12/21 - 11:48 am
Pfizer
Chantix
generics
Par Pharmaceuticals
varenicline
FDA
Takeda Settles "Pay-for-Delay" Consumer Claims for $1.85 Million
BioSpace
Thu, 08/12/21 - 12:07 am
Takeda
pay-for-delay
ADHD
generics
Teva’s generic label not skinny enough to protect from $234M damages to GSK
MedCity News
Sat, 08/7/21 - 11:57 pm
Teva Pharmaceutical
generics
labeling
patents
GSK
Coreg
Kaiser Sues Merck, Generic Drug Firm Over Millions in Losses Due to Alleged "Pay-for-Delay" Scheme
BioSpace
Thu, 07/29/21 - 11:08 pm
Merck
Kaiser Permanente
generics
pay-for-delay
Zetia
Vytorin
Biden wants to bolster the pharma supply chain. A major generic plant closing may make that harder
Stat
Tue, 07/27/21 - 10:24 am
generics
drug manufacturing
Joe Biden
supply chain
Viatris
Fight over “pay for delay” heats up in Washington
MedCity News
Thu, 07/22/21 - 10:17 pm
pay-for-delay
generics
innovation
legislation
Cost-cutting generics and biosimilars stuck in legal limbo
MedCity News
Thu, 07/22/21 - 10:58 am
generics
biosimilars
drug pricing
patents
Mylan sues generic rival Teva over 'sophisticated scheme' to block Copaxone copycats
Fierce Pharma
Thu, 07/1/21 - 11:08 pm
Teva Pharmaceutical
Mylan
Viatris
MS
generics
Copaxone
Viatris scores a win in long-running EpiPen antitrust lawsuit, but patent settlement charge heads to trial
Fierce Pharma
Fri, 06/25/21 - 11:09 am
EpiPen
generics
Mylan
Viatris
antitrust
Teva to Settle Mississippi Drug-Price Case, Seek More Pacts
Bloomberg
Wed, 06/23/21 - 10:34 am
Teva Pharmaceutical
Mississippi
generics
price fixing
Bristol Myers inks another Revlimid patent settlement—this time with Sun Pharma—as copycats near
Fierce Pharma
Tue, 06/22/21 - 10:49 pm
Bristol Myers Squibb
Celgene
Revlimid
generics
Sun Pharma
patents
Law banning copay coupons didn't boost generic drug use, study finds
Beckers Hospital Review
Mon, 06/21/21 - 10:21 pm
generics
copay coupons
California
Pages
« first
‹ previous
…
3
4
5
6
7
8
9
10
11
…
next ›
last »